(Reuters) -The U.S. Food and Drug Administration (FDA) has declined to approve Orexo AB’s high-dose prescription drug for opioid overdose, the company said on Tuesday. The […]

Rural regions like the one surrounding this southern Iowa town used to have a lot more babies and many more places to give birth to them. […]

An estimated two million people in England and Scotland were experiencing symptoms of long COVID as of March 2024, according to the Office for National Statistics. […]

Illicit use of the veterinary tranquilizer xylazine continues to spread across the United States. The drug, which is increasingly mixed with fentanyl, often fails to respond […]

Adolescents with non-segmental vitiligo who applied topical ruxolitinib, 1.5% cream were more likely than adults to achieve complete repigmentation, a post hoc analysis of pivotal clinical […]

It’s the difference between running a marathon and taking a leisurely stroll. That’s how recent pediatrics resident Joey Whelihan compared an 11-hour inpatient hospital day with […]

The combination of the antiviral bulevirtide (Hepcludex) plus pegylated interferon alfa-2a was superior to bulevirtide monotherapy for chronic hepatitis delta (HDV) infection, a multinational phase 2b […]

ORLANDO, Fla — A new analysis of a major study of the long-term effects of bariatric surgery failed to prove a mental health benefit for this […]

A debate about the impact of screen use in the education of children and adolescents is underway in the social, scientific, educational, and family spheres in […]